Attached files

file filename
10-K - 10-K - Replimune Group, Inc.tm2114346-1_10k.htm
EX-32.2 - EXHIBIT 32.2 - Replimune Group, Inc.tm2114346d3_ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - Replimune Group, Inc.tm2114346d3_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Replimune Group, Inc.tm2114346d3_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Replimune Group, Inc.tm2114346d3_ex31-1.htm
EX-21.1 - EXHIBIT 21.1 - Replimune Group, Inc.tm2114346d3_ex21-1.htm
EX-10.14 - EXHIBIT 10.14 - Replimune Group, Inc.tm2114346d3_ex10-14.htm
EX-10.13 - EXHIBIT 10.13 - Replimune Group, Inc.tm2114346d3_ex10-13.htm
EX-10.12 - EXHIBIT 10.12 - Replimune Group, Inc.tm2114346d3_ex10-12.htm
EX-10.11 - EXHIBIT 10.11 - Replimune Group, Inc.tm2114346d3_ex10-11.htm
EX-4.3 - EXHIBIT 4.3 - Replimune Group, Inc.tm2114346d3_ex4-3.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-244386) and Form S-8 (No. 333-226323) of Replimune Group, Inc. of our report dated May 20, 2021 relating to the financial statements, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

May 20, 2021